...
首页> 外文期刊>Hong Kong Journal of Paediatrics >Clinical Features of Bloodstream Infection in Children with Haematological Malignancies
【24h】

Clinical Features of Bloodstream Infection in Children with Haematological Malignancies

机译:血液系统恶性肿瘤患儿血液感染的临床特征

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Purpose: Sepsis and bacteraemia are both referred to as bloodstream infection (BSI). It contributed majorly to the mortality of the children with blood cancer. In order to reveal the clinical features of BSI and improve its outcome, we performed the investigation among the inpatients in haematology/oncology department. Methods: Neutropenia was defined as an absolute neutrophil count (ANC) in peripheral blood of 9/L. Microbiologically documented infection (MDI) was defined when causative pathogen was isolated from blood. Drug susceptibility test was performed using the VITEK-60 Auto Microbic System and Kirby-Baue disk diffusion method. Relative cytokines in the sera were detected through flow cytometry (FCM). All of the data were analysed with STATA software (version 9.0). Results: The incidence of BSI was 10.73% (161/1500), the rate of MDI for BSI was 43.48% (70/161). There was no statistical significance between non-MDI and MDI groups on the clinical characteristics. Total 79 strains were detected from 70 blood samples. Gram-positive bacteria, gram-negative bacteria and fungi accounted for 55.70% (44/79), 43.04% (34/79) and 1.27% (1/79), respectively. The most common pathogens were Staphylococcus epidermidis (20.25%), Escherichia coli (15.19%) and Klebsiella pneumoniae (15.19%). Staphylococcus showed no/low resistance to linezolid, vancomycin and furantoin. Gram-negative bacteria showed no/low resistance to cefoxitin, imipenem, piperacillin/tazobactam and amikacin. The mortality of BSI was 3.1% (5/161). Conclusions: BSI had no specific signs and symptoms clinically, and gram-positive bacteria were the dominant pathogens. Antibiotics selection according to the susceptibility test was superior to the empirical treatment. Improved prevention, early detection, and advanced therapeutic strategies might decrease the incidence of the BSI and improve its treatment outcome.
机译:目的:败血症和菌血症均被称为血流感染(BSI)。它在很大程度上增加了血液癌患儿的死亡率。为了揭示BSI的临床特征并改善其结局,我们在血液学/肿瘤科的住院患者中进行了调查。方法:中性粒细胞减少症定义为外周血中性粒细胞绝对计数(ANC)为9 / L。当从血液中分离出致病性病原体时,定义了微生物学上的感染(MDI)。使用VITEK-60 Auto Microbic System和Kirby-Baue纸片扩散法进行药敏试验。通过流式细胞仪(FCM)检测血清中的相对细胞因子。所有数据都使用STATA软件(9.0版)进行了分析。结果:BSI的发生率为10.73%(161/1500),MDI的发生率为43.48%(70/161)。非MDI组和MDI组之间的​​临床特征无统计学意义。从70个血液样本中检测到总共79个菌株。革兰氏阳性菌,革兰氏阴性菌和真菌分别占55.70%(44/79),43.04%(34/79)和1.27%(1/79)。最常见的病原体是表皮葡萄球菌(20.25%),大肠杆菌(15.19%)和肺炎克雷伯菌(15.19%)。葡萄球菌对利奈唑胺,万古霉素和呋喃妥因没有抗性/抵抗力低。革兰氏阴性细菌对头孢西丁,亚胺培南,哌拉西林/他唑巴坦和丁胺卡那霉素显示无/低耐药性。 BSI的死亡率为3.1%(5/161)。结论:BSI在临床上没有特定的症状和体征,革兰氏阳性细菌是主要病原体。根据药敏试验选择抗生素优于经验治疗。改进的预防,早期发现和先进的治疗策略可能会降低BSI的发生率并改善其治疗结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号